Zura Bio Stock (NASDAQ:ZURA)
Previous Close
$2.06
52W Range
$0.97 - $5.07
50D Avg
$1.68
200D Avg
$1.62
Market Cap
$131.34M
Avg Vol (3M)
$636.42K
Beta
-0.02
Div Yield
-
ZURA Company Profile
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.